Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 10286-10299

  Kropp, Kai A ^a   Robertson, Kevin A ^a   Sing, Garwin ^a   Rodriguez Martin, Sara ^a   Blanc, Mathieu ^a   Lacaze, Paul ^a   Hassim, Muhamad F B Noor ^a   Khondoker, Mizanur R ^a,f   Busche, Andreas ^b   Dickinson, Paul ^a   Forster, Thorsten ^a   Strobl, Birgit ^c   Mueller, Mathias ^c   Jonjic, Stipan ^d   Angulo, Ana ^e   Ghazal, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^d UNIVERSITY OF RIJEKA   (Croatia)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^f SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EMBRYO; ENZYME ACTIVATION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE INACTIVATION; IMMEDIATE EARLY GENE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALS; INTERFERON TYPE I; INTERFERON-GAMMA; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUROMEGALOVIRUS; SIGNAL TRANSDUCTION; TIME FACTORS;

CYTOMEGALOVIRUS; DNA VIRUSES; MURID HERPESVIRUS 1; MURINAE;

EID: 80053947344     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00373-11     Document Type: Article

References (85)

1. Angulo, A., P. Ghazal, and M. Messerle. 2000. The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth. J. Virol. 74:11129-11136.
2. Angulo, A., M. Messerle, U. H. Koszinowski, and P. Ghazal. 1998. Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J. Virol. 72:8502-8509.
3. Ank, N., et al. 2006. Lambda interferon (IFN-{lambda}), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80:4501-4509.
4. Benedict, C. A., et al. 2004. Neutrality of the canonical NF-{kappa}B-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J. Virol. 78:741-750.
5. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57:289-300.
6. Beutler, B., K. Crozat, J. A. Koziol, and P. Georgel. 2005. Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model. Curr. Opin. Immunol. 17:36-43.
7. Beutler, B., et al. 2005. Genetic analysis of innate resistance to mouse cytomegalovirus (MCMV). Brief. Funct. Genomic. Proteomic. 4:203-213.
8. Beutler, B., et al. 2006. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24:353-389.
9. Blanc, M., et al. 2011. Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol. 9:e1000598.
10. Bodaghi, B., et al. 1999. Role of IFN-γ-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J. Immunol. 162:957-964.
11. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
12. Borst, E. M., C. Benkartek, and M. Messerle. 2007. Use of bacterial artificial chromosomes in generating targeted mutations in human and mouse cytomegaloviruses, p. 1-30. In J. E. Coligan, B. Bierer, D. H. Margulies, E. M. Shevach, W. Strober, and R. Coico (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York, NY.
13. Brautigam, A. R., F. J. Dutko, L. B. Olding, and M. B. A. Oldstone. 1979. Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J. Gen. Virol. 44:349-359.
14. Chatellard, et al. 2007. The IE2 promoter/enhancer region from mouse CMV provides high levels of therapeutic protein expression in mammalian cells. Biotechnol. Bioeng. 96:106-117.
15. Cheung, G. Y. C., et al. 2008. Transcriptional responses of murine macrophages to the adenylate cyclase toxin of Bordetella pertussis. Microb. Pathog. 44:61-70.
16. Costa-Pereira, A. P., et al. 2002. The antiviral response to gamma interferon. J. Virol. 76:9060-9068.
17. Cox, C. 1990. Fieller's theorem, the likelihood and the delta method. Biometrics 46:709-718.
18. Der, S. D., A. Zhou, B. R. G. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 95:15623-15628.
19. de Veer, M. J., et al. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912-920.
20. Doelken, L., et al. 2008. High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA 14: 1959-1972.
21. Erlandsson, L., et al. 1998. Interferon-[beta] is required for interferon-[alpha] production in mouse fibroblasts. Curr. Biol. 8:223-226.
22. Fan, X. D., M. Goldberg, and B. R. Bloom. 1988. Interferon-gamma-induced transcriptional activation is mediated by protein kinase C. Proc. Natl. Acad. Sci. U. S. A. 85:5122-5125.
23. Freeman, T. C., et al. 2007. Construction, visualisation, and clustering of transcription networks from microarray expression data. PLoS Comput. Biol. 3:e206.
24. Friedman, R. L., S. P. Manly, M. McMahon, I. M. Kerr, and G. R. Stark. 1984. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38:745-755.
25. Gough, D. J., et al. 2010. Functional crosstalk between type I and II interferon through the regulated expression of STAT1. PLoS Biol. 8:e1000361.
26. Gribaudo, G., et al. 1993. Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197:303-311.
27. Gribaudo, G., et al. 1995. Interferon-a inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kB activity. Virology 211:251-260.
28. Gustems, M., et al. 2006. Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-{kappa}B binding sites in the enhancer. J. Virol. 80:9899-9904.
29. Hanson, L. K., and A. E. Campbell. 2006. Determinants of macrophage tropism, p. 419-443. In M. J. Reddehase and N. Lemmermann (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, England.
30. Heise, M. T., and H. W. Virgin. 1995. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:904-909.
31. Hengel, H., P. Lucin, S. Jonjic, T. Ruppert, and U. H. Koszinowski. 1994. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J. Virol. 68:289-297.
32. Holtappels, R., V. Boehm, J. Podlech, and M. Reddehase. 2008. CD8 T-cellbased immunotherapy of cytomegalovirus infection: proof of concept provided by the murine model. Med. Microbiol. Immunol. 197:125-134.
33. Holzinger, D., et al. 2007. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 81:7776-7785.
34. Honda, K., A. Takaoka, and T. Taniguchi. 2006. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:349-360.
35. Hummel, M., et al. 2001. Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J. Virol. 75:4814-4822.
36. Irizarry, R. A., et al. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
37. Jenner, R. G., and R. A. Young. 2005. Insights into host responses against pathogens from transcriptional profiling. Nat. Rev. Microbiol. 3:281-294.
38. Kalvakolanu, D. V. 2003. Alternate interferon signaling pathways. Pharmacol. Ther. 100:1-29.
39. Karaghiosoff, M., et al. 2000. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13:549-560.
40. Katze, M. G., Y. He, and M. Gale. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675-687.
41. Kerr, I. M., and G. R. Stark. 1992. The antiviral effects of the interferons and their inhibition. J. Interferon Res. 12:237-240.
42. Kotenko, S. V., et al. 2003. IFN-[lambda]s mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77.
43. Kropp, K. A., et al. 2009. Synergism between the components of the bipartite major immediate-early transcriptional enhancer of murine cytomegalovirus does not accelerate virus replication in cell culture and host tissues. J. Gen. Virol. 90:2395-2401.
44. Lacaze, P., et al. 2009. Combined genome-wide expression profiling and targeted RNA interference in primary mouse macrophages reveals perturbation of transcriptional networks associated with interferon signalling. BMC Genomics 10:372.
45. Landolfo, S., G. Gribaudo, A. Angeretti, and M. Gariglio. 1995. Mechanisms of viral inhibition by interferons. Pharmacol. Ther. 65:415-442.
46. Lecellier, C. H., et al. 2005. A cellular microRNA mediates antiviral defense in human cells. Science 308:557-560.
47. Lemmermann, N. A. W., et al. 2010. CD8 T-cell immunotherapy of cytomegalovirus disease in the murine model, p. 369-420. In S. Kaufmann and D. Kabelitz (ed.), Methods in microbiology and immunology of infection, vol. 25. Academic Press, New York, NY.
48. Liu, H., H. Kang, R. Liu, X. Chen, and K. Zhao. 2002. Maximal induction of a subset of interferon target genes requires the chromatin-remodeling activity of the BAF complex. Mol. Cell. Biol. 22:6471-6479.
49. Livet, J., et al. 2007. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450:56-62.
50. Lucin, P., et al. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J. Gen. Virol. 75:101-110.
51. Mangeat, B., et al. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103.
52. Matsumoto, M., et al. 1999. Activation of the transcription factor ISGF3 by interferon-gamma. Biol. Chem. 380:699-703.
53. Messerle, M., B. Buhler, G. M. Keil, and U. H. Koszinowski. 1992. Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J. Virol. 66:27-36.
54. Messerle, M., I. Crnkovic, W. Hammerschmidt, H. Ziegler, and U. H. Koszinowski. 1997. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U. S. A. 94:14759-14763.
55. Min, W., J. S. Pober, and D. R. Johnson. 1998. Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-alpha and the IFN-gamma signal-transduction pathways. Circ. Res. 83:815-823.
56. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045-1065.
57. Plachter, B., C. Sinzger, and G. Jahn. 1996. Cell types involved in replication and distribution of human cytomegalovirus. Adv. Virus Res. 46:195-261.
58. Podlech, J., R. Holtappels, N. K. A. Grzimek, and M. J. Reddehase. 2002. Animal models: murine cytomegalovirus, p. 493-525. In S. H. E. Kaufmann and D. Kabelitz (ed.), Methods in microbiology, vol. 32. Academic Press, San Diego, CA.
59. Podlech, J., et al. 2010. Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severely immunodeficient host tissues but fails in exponential growth. J. Virol. 84:6254-6261.
60. Presti, R. M., et al. 1998. Interferon-gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J. Exp. Med. 188:577-588.
61. Presti, R. M., D. L. Popkin, M. Connick, S. Paetzold, and H. W. Virgin. 2001. Novel cell type-specific antiviral mechanism of interferon-gamma action in macrophages. J. Exp. Med. 193:483-496.
62. R Development Core Team. 2011. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org.
63. Sadler, A. J., and B. R. G. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
64. Samarajiwa, S. A., S. Forster, K. Auchettl, and P. J. Hertzog. 2009. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res. 37:D852-D857.
65. Sarnow, P., C. L. Jopling, K. L. Norman, S. Schuetz, and K. A. Wehner. 2006. MicroRNAs: expression, avoidance and subversion by vertebrate viruses. Nat. Rev. Microbiol. 4:651-659.
66. Schlaak, J. F., et al. 2002. Cell-type and donor-specific transcriptional responses to interferon-alpha. J. Biol. Chem. 277:49428-49437.
67. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferongamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163-189.
68. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
69. Sinzger, C., et al. 1995. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in-vivo. J. Gen. Virol. 76:741-750.
70. Smith, M. G. 1954. Propagation of salivary gland virus of the mouse in tissue cultures. Proc. Soc. Exp. Biol. Med. 86:435-440.
71. Smyth, G. K. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:article 3.
72. Sommereyns, C., S. Paul, P. Staeheli, and T. Michiels. 2008. IFN-lambda is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 4:e1000017.
73. Staeheli, P. 1990. Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38:147-200.
74. Stark, G. R., I. M. Kerr, B. R. G. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
75. Stockinger, S., et al. 2002. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J. Immunol. 169:6522-6529.
76. Strobl, B., et al. 2005. Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus. J. Immunol. 175:4000-4008.
77. Takaoka, A., et al. 2000. Cross talk between interferon-gamma and -alpha/ beta signaling components in caveolar membrane domains. Science 288: 2357-2360.
78. Takaoka, A., and H. Yanai. 2006. Interferon signalling network in innate defence. Cell. Microbiol. 8:907-922.
79. Taniguchi, T., and A. Takaoka. 2001. A weak signal for strong responses: interferon-alpha/beta revisited. Nat. Rev. Mol. Cell Biol. 2:378-386.
80. Verhaegent, M., and T. K. Christopoulos. 2002. Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. Anal. Chem. 74:4378-4385.
81. Wagner, M., U. H. Koszinowski, and M. Messerle. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060.
82. Wurdinger, T., et al. 2008. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat. Methods 5:171-173.
83. Zhou, A., et al. 1995. Exogenous interferon-gamma induces endogenous synthesis of interferon-alpha and -beta by murine macrophages for induction of nitric oxide synthase. J. Interferon Cytokine Res. 15:897-904.
84. Zhou, Z., et al. 2007. Type III Interferon (IFN) Induces a Type I IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein Kinases. J. Virol. 81:7749-7758.
85. Zimmermann, A., et al. 2005. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J. Exp. Med. 201:1543-1553.